Reducing Risk of Esophageal Cancer in Barrett ' s Esophagus Reducing Risk of Esophageal Cancer in Barrett ' s Esophagus
Patients with Barrett ' s esophagus have a high risk of developing esophageal adenocarcinoma. Can PPIs and H2 receptor antagonists mitigate the risk?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Drugs & Pharmacology | Esophagus Cancer | Gastroenterology | Health | Proton Pump Inhibitors PPIs